AzTrials
AzTrials

Postoperative Pulmonary Complications (PPCs)FPB-PPCNCT07394816

Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery?

An observational study of Postoperative Pulmonary Complications (PPCs) and Abdominal Surgeries, run by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective observational study aims to evaluate whether the use of ultrasound-guided fascial plane blocks is associated with a lower incidence of postoperative pulmonary complications in adult patients undergoing elective major abdominal surgery under general anesthesia. Read more about this study

Who is it for?
Ages 65 years and older
How many people
500 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2026to 15 Aug 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: The study population consists of patients aged 65 years and older who are scheduled to undergo elective major abdominal surgery under general anesthesia. Eligible participants will be managed in a tertiary care hospital and will be allocated to either a fascial plane block group or a control group receiving standard perioperative analgesia. The study aims to evaluate postoperative outcomes in an elderly surgical population with comparable baseline characteristics.

Who may be able to join

  • Age 65 years or older
  • Scheduled for elective major abdominal surgery (e.g., colorectal, hepatobiliary, pancreatic, or gastric surgery)
  • ASA physical status II-III
  • Ability to provide written informed consent
  • Planned use of general anesthesia with or without adjunct regional techniques

Who cannot join

  • Refusal or inability to provide informed consent
  • Known allergy or contraindication to local anesthetics
  • Coagulopathy or ongoing anticoagulant therapy contraindicating regional anesthesia
  • Infection at the site of planned block
  • Pre-existing chronic opioid use or chronic pain syndrome
  • Severe hepatic, renal, or cardiac failure (e.g., Child-Pugh C, end-stage renal disease, EF <30%)
Show all 9Show fewer
  • Cognitive impairment or severe dementia preventing adequate pain assessment
  • Emergency surgery
  • Body mass index (BMI > 40 kg/m²)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital

    Yenimahalle, Ankara, 06370

    arif timuroglu, +905072601980, ariftimuroglu@yahoo.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Ultrasound-Guided Fascial Plane Blocks on Postoperative Pulmonary Complications in Patients Undergoing Major Abdominal Surgery: A Prospective Observational Study

This prospective observational study aims to evaluate whether the use of ultrasound-guided fascial plane blocks is associated with a lower incidence of postoperative pulmonary complications in adult patients undergoing elective major abdominal surgery under general anesthesia.

Patients will be observed in two groups based on routine clinical practice: those who receive an ultrasound-guided fascial plane block for postoperative analgesia and those managed with other standard analgesic methods. The choice of analgesic technique will be determined by the responsible anesthesia team and not influenced by the study.

Postoperative pulmonary complications occurring within the first 7 days after surgery will be recorded using reopening the European Perioperative Clinical Outcome (EPCO) criteria. Secondary outcomes will include unplanned intensive care unit admission, length of hospital stay, and 30-day mortality. No additional procedures or interventions will be performed for research purposes.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07394816
Study groupRoleWhat they receive
Fascial Plane Block GroupPatients undergoing elective major abdominal surgery who receive an ultrasound-guided fascial plane block at the end of surgery as part of routine clinical practice for postoperative analgesia. The decision to perform the block is made by the responsible anesthesia team and is not influenced by the study protocol.
Control GroupPatients undergoing elective major abdominal surgery who do not receive an ultrasound-guided fascial plane block and are managed with other routine postoperative analgesic methods, including epidural analgesia, intravenous patient-controlled analgesia, or oral analgesics, according to standard clinical practice.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of postoperative pulmonary complications (PPCs)

    Postoperative pulmonary complications will be defined and recorded according to the European Perioperative Clinical Outcome (EPCO) criteria.

    Measured: Within the first 7 postoperative days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2026
  2. Study start1 Mar 2026
  3. Primary completion1 Aug 2026 (estimated)
  4. Study completion15 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07394816
Sponsor's protocol ID
2025-12/186
Acronym
FPB-PPC
Status last verified
Apr 2026
First submitted
31 Jan 2026
Last updated
30 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to institutional policies and concerns regarding patient confidentiality and data protection.

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Pulmonary Complications (PPCs) and Abdominal Surgeries, run by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact arif timuroglu (+905072601980, ariftimuroglu@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of postoperative pulmonary complications (PPCs) (time frame: Within the first 7 postoperative days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in